Domestic and multinational companies focus on respective cardiovascular and anticancer treatments

Published: 2015-02-03 10:24:21

Updated: 2015-02-03 10:24:21

Last year, domestic companies went for cardiovascular pharmaceutical products while multinational companies had focused on anticancer drugs.

According to the analysis result of the approval state of clinical trials in 2014, the Ministry of Food and Drug Safety spoke that the total number of approvals increased to 652 cases, a 7.4 increase compared to the year of 2013.

While the number of appr...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.